Acasti Pharma (CVE:ACST) Shares Up 1.8% – Here’s What Happened

Acasti Pharma Inc. (CVE:ACST)’s stock price was up 1.8% during trading on Thursday . The company traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares traded hands during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.

Acasti Pharma Stock Up 1.8 %

The company has a debt-to-equity ratio of 0.52, a quick ratio of 9.41 and a current ratio of 9.74. The company has a market capitalization of C$25.87 million, a price-to-earnings ratio of -1.07 and a beta of 1.22. The business’s 50 day moving average is C$0.58 and its 200 day moving average is C$0.58.

About Acasti Pharma

Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.